View Single Post
Old 01-17-2007, 01:13 PM   #5
Becky
Senior Member
 
Becky's Avatar
 
Join Date: Sep 2005
Location: Stockton, NJ
Posts: 4,179
That's true Rhonda and it will soon be a moot point when Tykerb is FDA approved. However, when this trial started AC or EC was a standard of care (or FAC, FEC etc) for early Her2+ bc, so they wanted women who received ASCO's recommendation of standard of care.


It is the only way to really qualify results. This is evident in the HERA trial (receiving Herceptin after chemo vs during the taxane portion of chemo). The HERA results so far show Herceptin works just as well as if given with a taxane BUT... the HERA trial allowed any type of chemo (including CMF which doesn't work very well in Her2+ women) and they allowed node negative women (which the other trials did not). And the other trials all used the same kind of chemo - so the results are apples to apples.
__________________
Kind regards

Becky

Found lump via BSE
Diagnosed 8/04 at age 45
1.9cm tumor, ER+PR-, Her2 3+(rt side)
2 micromets to sentinel node
Stage 2A
left 3mm DCIS - low grade ER+PR+Her2 neg
lumpectomies 9/7/04
4DD AC followed by 4 DD taxol
Used Leukine instead of Neulasta
35 rads on right side only
4/05 started Tamoxifen
Started Herceptin 4 months after last Taxol due to
trial results and 2005 ASCO meeting & recommendations
Oophorectomy 8/05
Started Arimidex 9/05
Finished Herceptin (16 months) 9/06
Arimidex Only
Prolia every 6 months for osteopenia

NED 18 years!

Said Christopher Robin to Pooh: "You must remember this: You're braver than you believe and stronger than you seem and smarter than you think"
Becky is offline   Reply With Quote